Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 71Neoplasms 64Prostatic Neoplasms 45Colorectal Neoplasms 41Lung Neoplasms 37Carcinoma, Non-Small-Cell Lung 26Pancreatic Neoplasms 21Neoplasm Metastasis 20Hematologic Neoplasms 20Head and Neck Neoplasms 19Urinary Bladder Neoplasms 15Ovarian Neoplasms 14Multiple Myeloma 11Motor Activity 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Uterine Cervical Neoplasms 9Triple Negative Breast Neoplasms 9Glioblastoma 9Colonic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Glioma 8Gastrointestinal Neoplasms 8Carcinoma, Renal Cell 8COVID-19 8Anxiety Disorders 8Anatomic Stage I Breast Cancer AJCC v8 8Rectal Neoplasms 7Melanoma 7

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Surveys and Questionnaires 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Olanzapine 1Midazolam 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1Anesthesia, Spinal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Delirium × Standard of Care × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡